51
|
Scherpereel A, Cornelissen R, Di Pietro A, Kindler H, Nackaerts K, Antonia S, Calabrò L, Fu D, Robbins P, Ibrahim R, Maio M. Randomized, Double-Blind, Placebo-Controlled Study of Tremelimumab for Second-Line and Third-Line Treatment of Unresectable Pleural or Peritoneal Mesothelioma. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu342.27] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
52
|
Lewalter T, Kanagaratnam P, Schmidt B, Rosenqvist M, Nielsen-Kudsk JE, Ibrahim R, Albers BA, Camm AJ. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. Europace 2014; 16:626-30. [DOI: 10.1093/europace/euu069] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
|
53
|
Abualsaud AO, Freixa XR, Nosair M, Chan J, Tzikas A, Garceau P, Basmadjian A, Ibrahim R. Left Atrial Appendage Closure With a Second Generation Device. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
54
|
Riahi M, Ibrahim R. Transcatheter Closure of Large (>24 MM) Atrial Septal Defects. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
55
|
Pagé M, Freixa X, Chan J, Ibrahim R, Ibrahim R, Bonan R, Asgar A. Prognostic Significance of Myocardial Fibrosis Assessed by Cardiac Magnetic Resonance Imaging in Patients With Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
56
|
Tzikas A, Aguirre D, Velasco-Sanchez D, Freixa X, Alburquenque M, Khairy P, Bass JL, Ramirez J, Ibrahim R, Miro J. Transcatheter closure of perimembranous ventricular septal defect with a new occluder: one-year follow-up. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.p2077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
57
|
Ibrahim R, Ahmad N, Aziz MN. P065: Vancomycin resistant enterococci among patient in Kuala Lumpur Hospital, Malaysia: the occurence and its associated risk factors. Antimicrob Resist Infect Control 2013. [PMCID: PMC3688510 DOI: 10.1186/2047-2994-2-s1-p65] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
58
|
Ibrahim R, Chan J, Rofastes XF, Bonin R, Ibrahim R, Cartier R, Lamarche Y, Demers P, Asgar A. 176 Prevalence and Changes in MR Severity in High Risk Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): A Single Center Experience. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
59
|
Freixa X, Tzikas A, Sobrino A, Chan J, Basmadjian A, Ibrahim R. 362 Left Atrial Appendage Closure With the Amplatzer Cardiac Plug: Impact of Shape and Device Sizing on Follow-Up Leaks. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
60
|
Hanna B, Abadir S, Dallaire F, Rodes-Cabau J, Miro J, Dancea A, Ibrahim R, Dahdah N, Houde C. 359 Are Covered Stents Protective Against Acute Local Complications in High-Risk Patients With Aortic Coarctation? Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
61
|
Freixa X, Ibrahim R, Chan J, Asgar A. 800 The Gore Septal Occluder: Initial Experience. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
62
|
Ibrahim R, Avram R, Stevens L, Noiseux N, Gobeil F, Mansour S. 305 Prevalence, Clinical Characteristics and Management of Coronary Chronic Total Occlusions In Current Practice: A Canadian Single Center Experience. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
63
|
Ibrahim R, Noble S, Basmadjian A, Jolicoeur M, Levesque S, Potvin J. 568 Single Center Experience in Paravalvular Leak Closure: Procedural Success and Long-Term Follow-Up. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
64
|
Parhizkar S, Latiff L, Rahman S, Dollah M, Hanachi P, Ibrahim R, Tajeddin H. 219 SUPPLEMENTARY HEALTH BENEFITS OF LINOLEIC ACID BY IMPROVEMENT OF VAGINAL CORNIFICATION OF OVARIECTOMIZED RATS. Maturitas 2012. [DOI: 10.1016/s0378-5122(12)70330-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
65
|
Shah N, Bhojwani D, Silverman L, Whitlock J, Richards K, Stetler-Stevenson M, Buzoianu M, Ibrahim R, Pastan I, Wayne A. A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox (HA22, CAT-8015): Activity in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplantation (SCT). Biol Blood Marrow Transplant 2012. [DOI: 10.1016/j.bbmt.2011.12.091] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
66
|
Kouz R, Rheaume E, Berry C, Kernaleguen A, Brand G, Grégoire J, Ibrahim R, Lespérance J, L'Allier P, Noble S, Meyer P, Guertin M, Tardif J. 211 Circulating vegf concentrations are independently predictive of coronary artery disease severity measured by quantitative coronary angiography in patients with stable angina. Can J Cardiol 2011. [DOI: 10.1016/j.cjca.2011.07.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
67
|
Khandoker N, Hawkins S, Ibrahim R, Huynh C, Deng F. Tensile Strength of Spinnable Multiwall Carbon Nanotubes. ACTA ACUST UNITED AC 2011. [DOI: 10.1016/j.proeng.2011.04.424] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
68
|
Ibrahim R, Lwin Y. Adsorbents Derived from Mg-Al Hydrotalcite-Like Compounds for High-Temperature Hydrogen Storage. ACTA ACUST UNITED AC 2010. [DOI: 10.3923/jas.2010.1128.1133] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
69
|
Berry C, Noble S, Grégoire JC, Ibrahim R, Levesquie S, Lavoie MA, L'Allier PL, Tardif JC. Glycaemic status influences the nature and severity of coronary artery disease. Diabetologia 2010; 53:652-8. [PMID: 20225394 DOI: 10.1007/s00125-009-1651-x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
AIMS/HYPOTHESIS We sought to understand the relationships between glycaemic status and both severity and progression of coronary artery disease (CAD), the leading cause of death in diabetes. METHODS Baseline fasting blood glucose (FBG) and HbA1c (%)were measured in 426 patients with known or suspected stable CAD, who underwent coronary artery intravascular ultrasound(IVUS) at baseline and after a mean follow-up period of 664 days (range 257 to 961). The patients were categorised as normoglycaemic (n=226, 53%), or as having impaired fasting glucose (n=118, 28%) or diabetes (n=82, 19%). RESULTS The maximum percentage coronary atheroma area at baseline was greater in diabetic patients (73.33+/-8.86%) than in those with normoglycaemia (69.08+/-10.43%; p=0.001) and impaired fasting glucose (69.32+/-9.59%; p=0.0031). In averaged IVUS measurements of the 30-mm target segment(n=332 participants), change in percentage atheroma area during follow-up was also greater in the diabetes (1.86+/-3.90%) than in other groups (0.28+/-3.32% and 0.56+/-2.96%,p=0.0047 global). FBG correlated with maximum percentage atheroma area at baseline (r=0.17; p=0.0003). HbA1c also correlated with maximum percentage atheroma area at baseline (r=0.26; p=0.0001) and with change in maximum plaque area (r=0.16; p=0.016). A similar pattern of results occurred with plaque volume. The relationships between diabetes or HbA1c and both IVUS measurements of plaque burden and remodelling persisted after adjustment. CONCLUSIONS/INTERPRETATION Fasting blood glucose, HbA1c and the presence of diabetes are associated with the severity and progression of coronary atherosclerosis. These observations support the hypothesis that better glycaemic control may favourably influence CAD in patients with abnormal glucose tolerance or diabetes.
Collapse
|
70
|
El-Naggar W, Ibrahim R, Habib E, Gerorge S, Abd-Elmagid E. A Comparative study on gram-negative bacterial infections in Mansoura University Hospitals, Egypt. Int J Infect Dis 2010. [DOI: 10.1016/j.ijid.2010.02.1574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
71
|
O'Day SJ, Maio M, Chiarion-Sileni V, Gajewski TF, Pehamberger H, Bondarenko IN, Queirolo P, Lundgren L, Mikhailov S, Roman L, Verschraegen C, Humphrey R, Ibrahim R, de Pril V, Hoos A, Wolchok JD. Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol 2010; 21:1712-1717. [PMID: 20147741 DOI: 10.1093/annonc/mdq013] [Citation(s) in RCA: 390] [Impact Index Per Article: 27.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND This phase II study evaluated the safety and activity of ipilimumab, a fully human mAb that blocks cytotoxic T-lymphocyte antigen-4, in patients with advanced melanoma. PATIENTS AND METHODS Patients with previously treated, unresectable stage III/stage IV melanoma received 10 mg/kg ipilimumab every 3 weeks for four cycles (induction) followed by maintenance therapy every 3 months. The primary end point was best overall response rate (BORR) using modified World Health Organization (WHO) criteria. We also carried out an exploratory analysis of proposed immune-related response criteria (irRC). RESULTS BORR was 5.8% with a disease control rate (DCR) of 27% (N = 155). One- and 2-year survival rates (95% confidence interval) were 47.2% (39.5% to 55.1%) and 32.8% (25.4% to 40.5%), respectively, with a median overall survival of 10.2 months (7.6-16.3). Of 43 patients with disease progression by modified WHO criteria, 12 had disease control by irRC (8% of all treated patients), resulting in a total DCR of 35%. Adverse events (AEs) were largely immune related, occurring mainly in the skin and gastrointestinal tract, with 19% grade 3 and 3.2% grade 4. Immune-related AEs were manageable and generally reversible with corticosteroids. CONCLUSION Ipilimumab demonstrated clinical activity with encouraging long-term survival in a previously treated advanced melanoma population.
Collapse
|
72
|
Abidi M, Ratanatharathorn V, Abrams J, Ibrahim R, Cronin S, Al-Kadhimi Z, Lum L, Ventimiglia M, Ayash L, Uberti J. Aprepitant (AP) For Prevention Of Nausea And Vomiting Secondary To High-Dose Cyclophosphamide (Cy) Administered To Patients Undergoing Autologous (A) Peripheral Blood Progenitor Cell (Pbpc) Mobilization: Final Results Of A Phase Ii Trial. Biol Blood Marrow Transplant 2010. [DOI: 10.1016/j.bbmt.2009.12.140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
73
|
Siddiqui F, Ibrahim R, Elshaikh M, Lamerato L, Lu M, Pradhan D, Walker E, Stricker H, Freytag S, Movsas B. Does Socioeconomic Status (SES) Influence Outcome in Prostate Cancer Patients Treated with External Beam Radiation Therapy (EBRT)? Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
74
|
Grob J, Hamid O, Wolchok J, Maio M, Neyns B, Thomas L, de Pril V, Ibrahim R, O'Day S, Lebbé C. 9312 Antitumor responses to ipilimumab in advanced melanoma are not affected by systemic corticosteroids used to manage immune-related adverse events (irAEs). EUROPEAN JOURNAL OF CANCER SUPPLEMENTS 2009. [DOI: 10.1016/s1359-6349(09)71956-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
75
|
Onwuhafua P, Onwuhafua A, Omekara D, Ibrahim R. Ruptured uterus in Kaduna, Nigeria: a six-year review. J OBSTET GYNAECOL 2009; 18:419-23. [PMID: 15512133 DOI: 10.1080/01443619866688] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
A six year review in a Nigerian University Teaching Hospital revealed that the incidence of ruptured uterus is 1 per 137 deliveries. The mean age of patients was 30.5 years. Ruptured uterus occurred in younger women with a scarred uterus compared with the unscarred group. The incidence of ruptured uterus was highest in women who were para 5 and above. Cephalopelvic disproportion was the most important obstetric factor associated with rupture (63.4%). Abdominal tenderness (46.3%), vaginal bleeding (31.7%) and pallor (31.7%) were the commonest clinical features at presentation. Shock (22%) was commonest in the unscarred group. Repair with tubal sterilisation was the commonest method of treatment. Diarrhoea was the commonest postoperative complication (39%). Maternal and perinatal mortality rates were 22% and 88% respectively. Improving the emergency capability of the hospital and more efforts at educating our women and reducing poverty will go a long way towards reducing the incidence and adverse clinical outcome of ruptured uterus.
Collapse
|